Selective class I phosphoinositide 3-kinase inhibitors: optimization of a series of pyridyltriazines leading to the identification of a clinical candidate, AMG 511.
暂无分享,去创建一个
Daniel J. Freeman | J. McCarter | Nancy Zhang | D. Whittington | B. Herberich | A. Tasker | Bin Wu | R. Subramanian | Yunxin Y Bo | L. Pettus | Markian M Stec | N. Nishimura | S. Caenepeel | Longbin Liu | S. Booker | Noel D'angelo | Kevin C Yang | Leeanne P Zalameda | Ryan P. Wurz | E. Mullady | Xiaochun Zhu | Tisha San Miguel | A. Smith | N. Tamayo | P. Hughes | Divesh Aidasani | V. Cee | Claire L M Jackson | B. Lanman | A. B. Reed | Fang-Tsao Hong | Seifu Tadesse | Tian Wu | Ling Wang | K. Andrews | Jian Jiang | M. H. Norman